BACKGROUND: The ability to predict recovery of left ventricular ejection fraction (LVEF) in response to guideline-directed therapy among patients with nonischemic cardiomyopathy is desired. We sought ...

Background: Symptoms are among the most important factors impacting quality of life (QOL) in hypertrophic cardiomyopathy (HCM) patients, and reflect a poor prognosis. Whether emotional stress can ...

BACKGROUND: Patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction commonly experience ...

HCM is a relatively common genetic cardiomyopathy that can be a challenge to diagnose, with about one in three patients misdiagnosed as having another cardiomyopathy. Genetic testing identifies a ...

Diagnosis. Stress-induced (Takotsubo) cardiomyopathy (apical ballooning syndrome). Management. The patient was monitored with cardiac telemetry. Metoprolol and ramipril were continued. A 54-year ...

Rohit Bal has been suffering from a cardiac disease known as dilated cardiomyopathy for quite some time. It is a condition in ...

相关阅读：《减肥新药被列入药师【必要指导医药品】名录》点击文末“阅读原文”下载指南近些年来，减重药物的研发进展迅速，尤其是以胰高血糖素样肽-1 受体激动剂（glucagon-like peptide-1receptoragonist, GLP-1 ...

Researchers from Nanjing University and the Army Engineering University of PLA have published a review in ExRNA, shedding ...

Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space.

Reached alignment with FDA on key elements of registrational development plan for LX2006, including accelerated approval pathway with left-ventricular mass index (LVMI) and frataxin protein expression ...

Announced intent to file a biologics license application (BLA) for deramiocel to treat all patients with DMD-cardiomyopathy Rolling BLA submission initiated in October 2024 with full submission ...